• 1
    Callier P, Faivre L, Cusin V, Marle N, Thauvin-Robinet C, Sandre D, Rousseau T, Sagot P, Lacombe E, Faber V et al. (2005) Microcephaly is not mandatory for the diagnosis of mosaic variegated aneuploidy syndrome. Am J Med Genet A 137, 204207.
  • 2
    Rajagopalan H & Lengauer C (2004) Aneuploidy and cancer. Nature 432, 338341.
  • 3
    Holland AJ & Cleveland DW (2009) Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10, 478487.
  • 4
    Musacchio A (2011) Spindle assembly checkpoint: the third decade. Philos Trans R Soc Lond B Biol Sci 366, 35953604.
  • 5
    Cleveland DW, Mao Y & Sullivan KF (2003) Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell 112, 407421.
  • 6
    Musacchio A & Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8, 379393.
  • 7
    Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW & Vogelstein B (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300303.
  • 8
    Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R et al. (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797802.
  • 9
    Weaver BA & Cleveland DW (2007) Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res 67, 1010310105.
  • 10
    Nguyen T, Nioi P & Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284, 1329113295.
  • 11
    Motohashi H, O'Connor T, Katsuoka F, Engel JD & Yamamoto M (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294, 112.
  • 12
    Biswas M & Chan JY (2010) Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 244, 1620.
  • 13
    Lee CS, Lee C, Hu T, Nguyen JM, Zhang J, Martin MV, Vawter MP, Huang EJ & Chan JY (2011) Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci USA 108, 84088413.
  • 14
    Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY & Deshaies RJ (2010) Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 38, 1728.
  • 15
    Xing W, Singgih A, Kapoor A, Alarcon CM, Baylink DJ & Mohan S (2007) Nuclear factor-E2-related factor–1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J Biol Chem 282, 2205222061.
  • 16
    Narayanan K, Ramachandran A, Peterson MC, Hao J, Kolsto AB, Friedman AD & George A (2004) The CCAAT enhancer-binding protein (C/EBP)β and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J Biol Chem 279, 4542345432.
  • 17
    Xu Z, Chen L, Leung L, Yen TS, Lee C & Chan JY (2005) Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA 102, 41204125.
  • 18
    Wigge PA & Kilmartin JV (2001) The Ndc80p complex from Saccharomyces cerevisiae contains conserved centromere components and has a function in chromosome segregation. J Cell Biol 152, 349360.
  • 19
    Bharadwaj R, Qi W & Yu H (2004) Identification of two novel components of the human NDC80 kinetochore complex. J Biol Chem 279, 1307613085.
  • 20
    DeLuca JG, Dong Y, Hergert P, Strauss J, Hickey JM, Salmon ED & McEwen BF (2005) Hec1 and nuf2 are core components of the kinetochore outer plate essential for organizing microtubule attachment sites. Mol Biol Cell 16, 519531.
  • 21
    Bieche I, Vacher S, Lallemand F, Tozlu-Kara S, Bennani H, Beuzelin M, Driouch K, Rouleau E, Lerebours F, Ripoche H et al. (2011) Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy. Mol Cancer 10, 23.
  • 22
    Glinsky GV, Berezovska O & Glinskii AB (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115, 15031521.
  • 23
    Iwaizumi M, Shinmura K, Mori H, Yamada H, Suzuki M, Kitayama Y, Igarashi H, Nakamura T, Suzuki H, Watanabe Y et al. (2009) Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer. Gut 58, 249260.
  • 24
    Cheng L, Li L, Qiao X, Liu J & Yao X (2007) Functional characterization of the promoter of human kinetochore protein HEC1: novel link between regulation of the cell cycle protein and CREB family transcription factors. Biochim Biophys Acta 1769, 593602.
  • 25
    Masuoka HC & Townes TM (2002) Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 99, 736745.
  • 26
    Gordon DJ, Resio B & Pellman D (2012) Causes and consequences of aneuploidy in cancer. Nat Rev Genet 13, 189203.
  • 27
    Wiegand H, Wagner AE, Boesch-Saadatmandi C, Kruse HP, Kulling S & Rimbach G (2009) Effect of dietary genistein on Phase II and antioxidant enzymes in rat liver. Cancer Genomics Proteomics 6, 8592.
  • 28
    Pugalendhi P, Manoharan S, Panjamurthy K, Balakrishnan S & Nirmal MR (2009) Antigenotoxic effect of genistein against 7,12-dimethylbenz[a]anthracene induced genotoxicity in bone marrow cells of female Wistar rats. Pharmacol Rep 61, 296303.
  • 29
    Hernandez-Montes E, Pollard SE, Vauzour D, Jofre-Montseny L, Rota C, Rimbach G, Weinberg PD & Spencer JP (2006) Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochem Biophys Res Commun 346, 851859.
  • 30
    Wang W, Kwok AM & Chan JY (2007) The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem 282, 2467024678.